CABA Stock Analysis: Buy, Sell, or Hold?
CABA - Cabaletta Bio, Inc. Common Stock
$2.88
0.13 (4.55%)
▲
5d:
+2.68%
30d:
+1.59%
90d:
-13.14%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When CABA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: CABA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: CABA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: CABA is currently trading at $2.88, which is considered extended relative to its 30-day fair value range of $2.67 to $2.87.
Technical Outlook: Technically, CABA is in a downtrend. Immediate support is located at $2.64, while resistance sits at $3.00. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.38 (+386.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CABA is in a downtrend. Immediate support is located at $2.64, while resistance sits at $3.00. The stock is showing strong short-term momentum, up 4.5% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.38 (+386.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.67 -
$2.87
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
56.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.5%)
- BULLISH: Trading 386.4% below Wall St target ($13.38)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.67 -
$2.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.64
Resistance Level
$3.00
Current Trend
Downtrend
Technical data as of
Aug 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.88
Wall Street Target
$13.38
(+386.4%)
Share & Embed Analysis
Last updated: August 17, 2026 1:00 PM ET
Data refreshes hourly during market hours. Next update: 2:00 PM
Data refreshes hourly during market hours. Next update: 2:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CABA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$372 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 33 SELL |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$563 | 32 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 52 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
